25 Article(s)Download |
PMID | Title | Pub. Year | #Total Relationships |
1 | 29183962 | Intestinal lymphatic HDL miR-223 and ApoA-I are reduced during insulin resistance and restored with niacin. | 2018 Mar | 3 |
2 | 27891663 | Extended-release niacin increases anti-apolipoprotein A-I antibodies that block the antioxidant effect of high-density lipoprotein-cholesterol: the EXPLORE clinical trial. | 2017 May | 1 |
3 | 24285582 | Effect of niacin on high-density lipoprotein apolipoprotein A-I kinetics in statin-treated patients with type 2 diabetes mellitus. | 2014 Feb | 2 |
4 | 24956528 | Niacin decreases leukocyte myeloperoxidase: mechanistic role of redox agents and Src/p38MAP kinase. | 2014 Aug | 4 |
5 | 22990043 | Niacin administration significantly reduces oxidative stress in patients with hypercholesterolemia and low levels of high-density lipoprotein cholesterol. | 2013 Mar | 1 |
6 | 24079282 | Differential effects of fenofibrate and extended-release niacin on high-density lipoprotein particle size distribution and cholesterol efflux capacity in dyslipidemic patients. | 2013 Sep-Oct | 1 |
7 | 22389325 | Niacin increases HDL biogenesis by enhancing DR4-dependent transcription of ABCA1 and lipidation of apolipoprotein A-I in HepG2 cells. | 2012 May | 3 |
8 | 22500948 | Consistency of extended-release niacin/laropiprant effects on Lp(a), ApoB, non-HDL-C, Apo A1, and ApoB/ApoA1 ratio across patient subgroups. | 2012 Jun 1 | 2 |
9 | 21664629 | Nicotinic acid induces apolipoprotein A-I gene expression in HepG2 and Caco-2 cell lines. | 2011 Dec | 14 |
10 | 18602814 | Effects of niacin and chromium on the expression of ATP-binding cassette transporter A1 and apolipoprotein A-1 genes in HepG2 cells. | 2009 Apr | 2 |
11 | 19166694 | Effect of combination nicotinic acid and gemfibrozil treatment on intermediate density lipoprotein, and subclasses of low density lipoprotein and high density lipoprotein in patients with combined hyperlipidemia. | 2009 Feb 1 | 1 |
12 | 19797938 | Niacin promotes cholesterol efflux through stimulation of the PPARgamma-LXRalpha-ABCA1 pathway in 3T3-L1 adipocytes. | 2009 | 3 |
13 | 18375237 | Mechanism of action of niacin. | 2008 Apr 17 | 6 |
14 | 18566298 | Extended-release niacin alters the metabolism of plasma apolipoprotein (Apo) A-I and ApoB-containing lipoproteins. | 2008 Sep | 3 |
15 | 18047854 | Nicotinic acid (niacin) receptor agonists: will they be useful therapeutic agents? | 2007 Dec 3 | 3 |
16 | 17319473 | Evaluation of efficacy and safety of fixed dose lovastatin and niacin(ER) combination in asian Indian dyslipidemic patients: a multicentric study. | 2006 | 1 |
17 | 15539964 | Rosuvastatin alone or with extended-release niacin: a new therapeutic option for patients with combined hyperlipidemia. | 2004 Fall | 1 |
18 | 15539965 | The effects of niacin on lipoprotein subclass distribution. | 2004 Fall | 1 |
19 | 12637338 | Change in alpha1 HDL concentration predicts progression in coronary artery stenosis. | 2003 May 1 | 1 |
20 | 12767421 | Beneficial effects of rosuvastatin alone and in combination with extended-release niacin in patients with a combined hyperlipidemia and low high-density lipoprotein cholesterol levels. | 2003 Jun 1 | 1 |
21 | 14605511 | Once-daily niacin extended release/lovastatin combination tablet has more favorable effects on lipoprotein particle size and subclass distribution than atorvastatin and simvastatin. | 2003 Fall | 1 |
22 | 11701466 | Niacin, but not gemfibrozil, selectively increases LP-AI, a cardioprotective subfraction of HDL, in patients with low HDL cholesterol. | 2001 Nov | 1 |
23 | 9351367 | Niacin decreases removal of high-density lipoprotein apolipoprotein A-I but not cholesterol ester by Hep G2 cells. Implication for reverse cholesterol transport. | 1997 Oct | 8 |
24 | 6403042 | Subpopulations of apolipoprotein A-I in human high-density lipoproteins. Their metabolic properties and response to drug therapy. | 1983 Apr 13 | 1 |
25 | 221531 | Effects of nicotinic acid therapy on plasma high density lipoprotein subfraction distribution and composition and on apolipoprotein A metabolism. | 1979 May | 5 |